Fujifilm Diosynth Biotechnologies signed a 10-year manufacturing contract with Regeneron. 1. AstraZeneca, Daiichi say Enhertu delivers 'highly statistically significant' efficacy in first-line ...

Regeneron Pharmaceuticals has a 52-week low of $525.99 and a 52-week high of $1,211.20. The firm has a market capitalization of $65.57 billion, a PE ratio of 15.67, a price-to-earnings-growth ...

From budget-friendly options to smart rings and rugged outdoor smartwatches, these are the best fitness trackers we have tested. Finding the right fitness tracker for you does not just tick a box ...

Looking for one of the best fitness trackers? Whether you’re training for a marathon, working on your overall fitness, or just want an easy way to track your daily steps, calories burned, heart rate, ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› by Duncan Niederlitz and Eve O'Neill We tested nearly 40 bike locks, and ...

Whether you want to count steps, track your sleep or boost your running performance, these are the best fitness trackers to buy on a tight budget. When you purchase through links on our site ...

$3 billion FUJIFILM deal will nearly double Regeneron’s large-scale U.S. biologics manufacturing capacity over the next decade. Regeneron adds 7,000+ U.S. jobs in five years, with $7B+ in ...

Regeneron continues to invest heavily in its New York State operations, where an approximately $3.6 billion expansion of its Tarrytown campus is underway, creating 1,000 full-time, high-skill jobs ...

Regeneron Pharmaceuticals Inc. agreed to pay Fujifilm Diosynth Biotechnologies more than $3 billion over the next decade to help manufacture its medicines in the US, as the threat of tariffs looms ...

Regeneron continues to invest heavily in its New York State operations, where an approximately $3.6 billion expansion of its Tarrytown campus is underway, creating 1,000 full-time, high-skill jobs ...

Under the terms of the agreement, FUJIFILM Diosynth Biotechnologies will provide US-based manufacturing for Regeneron over the 10-year period through current and planned expansions at its new ...